Skip to main content
Top

31-10-2024 | Biomarkers | IM - ORIGINAL

Characterization of potential salivary biomarkers in Behçet’s disease

Authors: Mohammad S. Alrashdan, Diana Alnemri, Firas A. Al-Qarqaz, Khaldoon M. Alawneh, Natheer H Al-Rawi, Amal Bouzid, Mahmoud Khaled AL-Omiri

Published in: Internal and Emergency Medicine

Login to get access

Abstract

Diagnosis of Behçet’s disease (BD) has always been a challenging task due to the heterogeneity and complexity of the disease, while available literature on BD biomarkers is largely inconclusive. The aim of this study was to evaluate the expression of a panel of salivary biomarkers in a group of BD patients and test their association with BD. The study population comprised 23 BD patients (12 females and 11 males) and a control group of age and gender-matched healthy individuals. Enzyme-linked immunosorbent assays were used to test the expression of 5 salivary proteins including: interleukin 1β (IL-1β), epidermal growth factor (EGF), endothelin, vascular endothelial growth factor (VEGF) and transferrin (TrF). BD activity was evaluated using the International Society for Behçet’s disease (ISBD) current activity form. Salivary endothelin, EGF and VEGF were significantly higher in the BD group compared to controls (16.3 Vs. 7.7 pg/ml, 194.5 Vs. 163.4 pg/ml and 262 Vs. 150.2 pg/ml, p<0.05, respectively) whereas TrF was significantly lower in BD group compared to controls (497 Vs. 2206 pg/ml, p<0.001). The correlation analysis showed a trend of a positive linear association between endothelin expression and both BD activity (r=0.41) and BD activity index score (r=0.4), without reaching statistical significance (p>0.05). In conclusion, salivary TrF, endothelin, VEGF and EGF may represent potential biomarkers for BD. These findings require further validation in larger samples and different activity states of BD.
Literature
1.
go back to reference Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2020) One year in review 2020: Behcet’s syndrome. Clin Exp Rheumatol 38 Suppl 127(5):3–10PubMed Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2020) One year in review 2020: Behcet’s syndrome. Clin Exp Rheumatol 38 Suppl 127(5):3–10PubMed
2.
go back to reference Ambrose NL, Haskard DO (2013) Differential diagnosis and management of Behcet syndrome. Nat Rev Rheumatol 9(2):79–89CrossRefPubMed Ambrose NL, Haskard DO (2013) Differential diagnosis and management of Behcet syndrome. Nat Rev Rheumatol 9(2):79–89CrossRefPubMed
3.
go back to reference Behcet H (1937) Uber rezidivierende, aphtose, durch ein virus verursachte geschrwre am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152–1157 Behcet H (1937) Uber rezidivierende, aphtose, durch ein virus verursachte geschrwre am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152–1157
4.
go back to reference Zouboulis CC, Keitel W (2002) A historical review of early descriptions of Adamantiades-Behcet’s disease. J Investig Dermatol 119(1):201CrossRefPubMed Zouboulis CC, Keitel W (2002) A historical review of early descriptions of Adamantiades-Behcet’s disease. J Investig Dermatol 119(1):201CrossRefPubMed
5.
go back to reference Cakir N, Dervis E, Benian O, Pamuk O, Sonmezates N, Rahimoglu R, Tuna S, Cetin T, Sarikaya Y (2004) Prevalence of Behçet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 22:S53–S55PubMed Cakir N, Dervis E, Benian O, Pamuk O, Sonmezates N, Rahimoglu R, Tuna S, Cetin T, Sarikaya Y (2004) Prevalence of Behçet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 22:S53–S55PubMed
6.
go back to reference Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Behçet disease: evolution of clinical manifestations. Medicine 90(2):125–132CrossRefPubMed Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Behçet disease: evolution of clinical manifestations. Medicine 90(2):125–132CrossRefPubMed
7.
go back to reference Madanat WY, Alawneh KM, Smadi MM, Saadeh SS, Omari MM, Bani Hani A (2017) The prevalence of Behçet’s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol 35(Suppl 108):51–54PubMed Madanat WY, Alawneh KM, Smadi MM, Saadeh SS, Omari MM, Bani Hani A (2017) The prevalence of Behçet’s disease in the north of Jordan: a hospital-based epidemiological survey. Clin Exp Rheumatol 35(Suppl 108):51–54PubMed
8.
go back to reference Scherrer MAR, Rocha VB, Garcia LC (2017) Behcet’s disease: review with emphasis on dermatological aspects. An Brasileiros De Dermatol 92:452–464CrossRef Scherrer MAR, Rocha VB, Garcia LC (2017) Behcet’s disease: review with emphasis on dermatological aspects. An Brasileiros De Dermatol 92:452–464CrossRef
9.
go back to reference Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, Mat C, Yurdakul S, Yazici H (2010) Prognosis of Behcet’s syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology 49(1):173–177CrossRefPubMed Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, Mat C, Yurdakul S, Yazici H (2010) Prognosis of Behcet’s syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology 49(1):173–177CrossRefPubMed
10.
go back to reference Parsaei A, Moradi S, Masoumi M, Davatchi F, Najafi A, Kooshki AM, Hajighadery A, Akhlaghi M, Faezi T, Kavosi H (2022) Predictive value of erythrocyte sedimentation rate and C-reactive protein in Behcet’s disease activity and manifestations: a cross-sectional study. BMC Rheumatol 6(1):9CrossRefPubMedPubMedCentral Parsaei A, Moradi S, Masoumi M, Davatchi F, Najafi A, Kooshki AM, Hajighadery A, Akhlaghi M, Faezi T, Kavosi H (2022) Predictive value of erythrocyte sedimentation rate and C-reactive protein in Behcet’s disease activity and manifestations: a cross-sectional study. BMC Rheumatol 6(1):9CrossRefPubMedPubMedCentral
11.
go back to reference Nowatzky J (2009) Biomarkers in Behçet’s disease: diagnosis and disease activity. Int J Clin Rheumatol 4(3):271CrossRef Nowatzky J (2009) Biomarkers in Behçet’s disease: diagnosis and disease activity. Int J Clin Rheumatol 4(3):271CrossRef
14.
go back to reference Spielmann N, Wong DT (2011) Saliva: diagnostics and therapeutic perspectives. Oral Dis 17(4):345–354CrossRefPubMed Spielmann N, Wong DT (2011) Saliva: diagnostics and therapeutic perspectives. Oral Dis 17(4):345–354CrossRefPubMed
15.
go back to reference Adışen E, Aral A, Aybay C, Gürer MA (2008) Salivary epidermal growth factor levels in Behçet’s disease and recurrent aphthous stomatitis. Dermatology 217(3):235–240CrossRefPubMed Adışen E, Aral A, Aybay C, Gürer MA (2008) Salivary epidermal growth factor levels in Behçet’s disease and recurrent aphthous stomatitis. Dermatology 217(3):235–240CrossRefPubMed
16.
go back to reference Hodeib AA, Elsharawy TA, Fawzi HA (2010) Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in Behcet’s disease. Indian J Dermatol 55(3):215CrossRefPubMedPubMedCentral Hodeib AA, Elsharawy TA, Fawzi HA (2010) Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in Behcet’s disease. Indian J Dermatol 55(3):215CrossRefPubMedPubMedCentral
17.
go back to reference Zhan H, Li H, Liu C, Cheng L, Yan S, Li Y (2021) Association of circulating vascular endothelial growth factor levels with autoimmune diseases: a systematic review and meta-analysis. Front Immunol 12:674343CrossRefPubMedPubMedCentral Zhan H, Li H, Liu C, Cheng L, Yan S, Li Y (2021) Association of circulating vascular endothelial growth factor levels with autoimmune diseases: a systematic review and meta-analysis. Front Immunol 12:674343CrossRefPubMedPubMedCentral
18.
go back to reference Rao R, Thomas D, Pepperl S, Porreca F (1997) Salivary epidermal growth factor plays a role in protection of ileal mucosal integrity. Digestive Dis Sci 42:2175–2181CrossRef Rao R, Thomas D, Pepperl S, Porreca F (1997) Salivary epidermal growth factor plays a role in protection of ileal mucosal integrity. Digestive Dis Sci 42:2175–2181CrossRef
19.
go back to reference Huang N, Zhan LL, Cheng Y, Wang XL, Wei YX, Wang Q, Li WJ (2020) TfR1 extensively regulates the expression of genes associated with ion transport and immunity. Curr Med Sci 40(3):493–501CrossRefPubMed Huang N, Zhan LL, Cheng Y, Wang XL, Wei YX, Wang Q, Li WJ (2020) TfR1 extensively regulates the expression of genes associated with ion transport and immunity. Curr Med Sci 40(3):493–501CrossRefPubMed
20.
go back to reference Falsafi P, Khorshidi-Khiavi R, Ghanizadeh M, Rezaei F, Dolatkhah H, Bahramian A, Pirayesh T (2019) Salivary transferrin levels in patients with oral lichen planus. Pesqui Brasileira Em Odontopediatria E Clín Integr 19:e4350 Falsafi P, Khorshidi-Khiavi R, Ghanizadeh M, Rezaei F, Dolatkhah H, Bahramian A, Pirayesh T (2019) Salivary transferrin levels in patients with oral lichen planus. Pesqui Brasileira Em Odontopediatria E Clín Integr 19:e4350
21.
go back to reference Belstrøm D, Eiberg JM, Enevold C, Grande MA, Jensen CAJ, Skov L, Hansen PR (2020) Salivary microbiota and inflammation-related proteins in patients with psoriasis. Oral Dis 26(3):677–687CrossRefPubMedPubMedCentral Belstrøm D, Eiberg JM, Enevold C, Grande MA, Jensen CAJ, Skov L, Hansen PR (2020) Salivary microbiota and inflammation-related proteins in patients with psoriasis. Oral Dis 26(3):677–687CrossRefPubMedPubMedCentral
22.
go back to reference Criteria for diagnosis of Behçet’s disease (1990) International study group for Behçet’s disease. Lancet 335(8697):1078–1080 Criteria for diagnosis of Behçet’s disease (1990) International study group for Behçet’s disease. Lancet 335(8697):1078–1080
23.
go back to reference Bhakta B, Brennan P, James T, Chamberlain M, Noble B, Silman A (1999) Behcet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38(8):728–733CrossRefPubMed Bhakta B, Brennan P, James T, Chamberlain M, Noble B, Silman A (1999) Behcet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38(8):728–733CrossRefPubMed
24.
go back to reference Lawton G, Bhakta B, Chamberlain M, Tennant A (2004) The Behcet’s disease activity index. Rheumatology 43(1):73–78CrossRefPubMed Lawton G, Bhakta B, Chamberlain M, Tennant A (2004) The Behcet’s disease activity index. Rheumatology 43(1):73–78CrossRefPubMed
25.
go back to reference Mumcu G, Cimilli H, Karacayli U, Inanc N, Ture-Ozdemir F, Eksioglu-Demiralp E, Ergun T, Direskeneli H (2012) Salivary levels of antimicrobial peptides Hnp 1–3, Ll-37 and S100 in Behcet’s disease. Arch Oral Biol 57(6):642–646CrossRefPubMed Mumcu G, Cimilli H, Karacayli U, Inanc N, Ture-Ozdemir F, Eksioglu-Demiralp E, Ergun T, Direskeneli H (2012) Salivary levels of antimicrobial peptides Hnp 1–3, Ll-37 and S100 in Behcet’s disease. Arch Oral Biol 57(6):642–646CrossRefPubMed
26.
go back to reference Molet S, Furukawa K, Maghazechi A, Hamid Q, Giaid A (2000) Chemokine-and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells. J Allerg Clin Immunol 105(2):333–338CrossRef Molet S, Furukawa K, Maghazechi A, Hamid Q, Giaid A (2000) Chemokine-and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells. J Allerg Clin Immunol 105(2):333–338CrossRef
27.
go back to reference Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S, Ciolkiewicz M (2006) A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. Clin Rheumatol 25(3):314–319CrossRefPubMed Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S, Ciolkiewicz M (2006) A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. Clin Rheumatol 25(3):314–319CrossRefPubMed
28.
go back to reference Przepiera-Będzak H, Fischer K, Brzosko M (2016) Serum interleukin-18, fetuin-A, soluble intercellular adhesion molecule-1, and endothelin-1 in ankylosing spondylitis, psoriatic arthritis, and SAPHO syndrome. Int J Mol Sci 17(8):1255CrossRefPubMedPubMedCentral Przepiera-Będzak H, Fischer K, Brzosko M (2016) Serum interleukin-18, fetuin-A, soluble intercellular adhesion molecule-1, and endothelin-1 in ankylosing spondylitis, psoriatic arthritis, and SAPHO syndrome. Int J Mol Sci 17(8):1255CrossRefPubMedPubMedCentral
29.
go back to reference Er H, Evereklioglu C, Cumurcu T, Türköz Y, Özerol E, Şahin K, Doganay S (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet’s disease. Br J Ophthalmol 86(6):653–657CrossRefPubMedPubMedCentral Er H, Evereklioglu C, Cumurcu T, Türköz Y, Özerol E, Şahin K, Doganay S (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet’s disease. Br J Ophthalmol 86(6):653–657CrossRefPubMedPubMedCentral
30.
go back to reference Lie J (1992) Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 19(3):341–343PubMed Lie J (1992) Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 19(3):341–343PubMed
31.
go back to reference Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/antioxidant status in patients with Behçet’s disease. Ann Clin Lab Sci 32(4):377–382PubMed Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/antioxidant status in patients with Behçet’s disease. Ann Clin Lab Sci 32(4):377–382PubMed
32.
go back to reference Dikker O, Yildirmak S, Şahin M, Murat U, Vardar M, Vurgun E, Çiçek Y, Durmuşcan M, Altun Z, Baran F (2019) Serum hepcidin levels in active and inactive Behcet’s disease. Ortadoğu Tıp Dergisi 11(1):63–72CrossRef Dikker O, Yildirmak S, Şahin M, Murat U, Vardar M, Vurgun E, Çiçek Y, Durmuşcan M, Altun Z, Baran F (2019) Serum hepcidin levels in active and inactive Behcet’s disease. Ortadoğu Tıp Dergisi 11(1):63–72CrossRef
33.
go back to reference Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM (2001) Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum Official J Am Coll Rheumatol 44(9):2055–2064CrossRef Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM (2001) Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum Official J Am Coll Rheumatol 44(9):2055–2064CrossRef
34.
go back to reference Fava RA, Olsen NJ, Spencer-Green G, Yeo K-T, Yeo T-K, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180(1):341–346CrossRefPubMed Fava RA, Olsen NJ, Spencer-Green G, Yeo K-T, Yeo T-K, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180(1):341–346CrossRefPubMed
35.
go back to reference Flisiak I, Zaniewski P, Rogalska M, Myśliwiec H, Jaroszewicz J, Chodynicka B (2010) Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales. Cytokine 52(3):225–229CrossRefPubMed Flisiak I, Zaniewski P, Rogalska M, Myśliwiec H, Jaroszewicz J, Chodynicka B (2010) Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales. Cytokine 52(3):225–229CrossRefPubMed
36.
go back to reference Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, Galimberti D, Del Fabbro M, Tartaglia GM (2023) Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. Int J Oral Sci 15(1):27CrossRefPubMedPubMedCentral Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, Galimberti D, Del Fabbro M, Tartaglia GM (2023) Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. Int J Oral Sci 15(1):27CrossRefPubMedPubMedCentral
37.
go back to reference Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, Sorsa T, Gustafsson A (2013) Salivary biomarkers for detection of systemic diseases. PloS one 8(4):e61356CrossRefPubMedPubMedCentral Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, Sorsa T, Gustafsson A (2013) Salivary biomarkers for detection of systemic diseases. PloS one 8(4):e61356CrossRefPubMedPubMedCentral
39.
go back to reference Leung YY, Hui LLY, Kraus VB (2015) Colchicine—update on mechanisms of action and therapeutic uses. In: Leung YY, Hui LLY, Kraus VB (eds) Seminars in arthritis and rheumatism. Elsevier, Amsterdam, pp 341–350 Leung YY, Hui LLY, Kraus VB (2015) Colchicine—update on mechanisms of action and therapeutic uses. In: Leung YY, Hui LLY, Kraus VB (eds) Seminars in arthritis and rheumatism. Elsevier, Amsterdam, pp 341–350
Metadata
Title
Characterization of potential salivary biomarkers in Behçet’s disease
Authors
Mohammad S. Alrashdan
Diana Alnemri
Firas A. Al-Qarqaz
Khaldoon M. Alawneh
Natheer H Al-Rawi
Amal Bouzid
Mahmoud Khaled AL-Omiri
Publication date
31-10-2024
Publisher
Springer International Publishing
Keyword
Biomarkers
Published in
Internal and Emergency Medicine
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-024-03801-6

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Live: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more